bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version proquest investments  home proquest associates iv llc institutional portfolio new positions  nasdaqcom hot topics etfs  smart portfolio  currencies  online broker center search home  quotes  ownership  insider trades  institutional portfolio proquest associates iv llc  vanderbilt beach road naples florida    no holdings for this institution latest news headlines rockwell collins revenue jumps  pct am et   reuters southside bancshares inc announces financial results for the three and six months ended june  am et   globenewswire us republican effort to gut obamacare ends in defeat for trump am et   reuters rpttrump urged washington to stop bank mergers in  letter am et   reuters redfin nasdaq rdfn to ring the nasdaq stock market opening bell in celebration of its ipo am et   globenewswire view all latest headlines closex edit favorites enter up to  symbols separated by commas or spaces in the text box below these symbols will be available during your session for use on applicable pages update clear list closex customize your nasdaqcom experience background color selector select the background color of your choice  black  slate gray  light gray  gray blue quote search select a default target page for your quote search  realtime  after hours  premarket  news  flash quote  summary quote  interactive charts  default setting please note that once you make your selection it will apply to all future visits to nasdaqcom if at any time you are interested in reverting to our default settings please select default setting above if you have any questions or encounter any issues in changing your default settings please email isfeedbacknasdaqcom closex please confirm your selection you have selected to change your default setting for the quote search this will now be your default target page unless you change your configuration again or you delete your cookies are you sure you want to change your settings yes no closex please disable your ad blocker or update your settings to ensure that javascript and cookies are enabled so that we can continue to provide you with the firstrate market news and data youve come to expect from us closex ﻿ proquest associates iv llc sells  shares of eagle pharmaceuticals inc nasdaqegrx  stock observer daily ratings  news for eagle pharmaceuticals inc complete the form below to receive the latest headlines and analysts recommendationsfor eagle pharmaceuticals inc with our free daily email newsletter follow storminvestor recent posts sophos group plc soph receives gbx  consensus target price from analysts halliburton company forecasted to earn fy earnings of  per share nysehal headtohead comparison hsn nasdaqhsni  five below five barratt developments plc lonbdev stock rating reaffirmed by peel hunt barclays plc raises incyte corporation nasdaqincy price target to  first midwest bank trust division cuts stake in simon property group inc nysespg first midwest bank trust division decreases position in apache corporation apa spdr sp  etf trust nysespy is legacy wealth management inc’s th largest position assurant inc aiz position cut by regentatlantic capital llc united therapeutics corporation uthr position decreased by regentatlantic capital llc regentatlantic capital llc has  million position in ashland global holdings inc nyseash marsh  mclennan companies inc mmc shares sold by regentatlantic capital llc bank of america corporation upgrades korea electric power corporation kep to “buy” lululemon athletica inc lulu raised to “buy” at bidaskclub instructure inc inst stock rating lowered by zacks investment research contrasting super micro computer smci  sigma designs sigm jinkosolar holding company limited jks shares sold by guinness atkinson asset management inc diane musi sells  shares of carecom inc nysecrcm stock huttig building products hbp receives daily coverage optimism score of  somewhat favorable media coverage somewhat unlikely to impact psychemedics corporation pmd share price proquest associates iv llc sells  shares of eagle pharmaceuticals inc nasdaqegrx posted by stanley muller on jul th   no comments proquest associates iv llc cut its position in eagle pharmaceuticals inc nasdaqegrx by  during the first quarter according to its most recent form f filing with the sec the fund owned  shares of the specialty pharmaceutical company’s stock after selling  shares during the period eagle pharmaceuticals makes up approximately  of proquest associates iv llc’s holdings making the stock its largest position proquest associates iv llc owned  of eagle pharmaceuticals worth  at the end of the most recent quarter a number of other large investors have also modified their holdings of egrx blackrock inc boosted its stake in shares of eagle pharmaceuticals by  in the first quarter blackrock inc now owns  shares of the specialty pharmaceutical company’s stock worth  after buying an additional  shares in the last quarter victory capital management inc boosted its stake in shares of eagle pharmaceuticals by  in the first quarter victory capital management inc now owns  shares of the specialty pharmaceutical company’s stock worth  after buying an additional  shares in the last quarter iridian asset management llc ct boosted its stake in shares of eagle pharmaceuticals by  in the first quarter iridian asset management llc ct now owns  shares of the specialty pharmaceutical company’s stock worth  after buying an additional  shares in the last quarter first eagle investment management llc boosted its stake in shares of eagle pharmaceuticals by  in the first quarter first eagle investment management llc now owns  shares of the specialty pharmaceutical company’s stock worth  after buying an additional  shares in the last quarter finally state street corp boosted its stake in shares of eagle pharmaceuticals by  in the fourth quarter state street corp now owns  shares of the specialty pharmaceutical company’s stock worth  after buying an additional  shares in the last quarter get eagle pharmaceuticals inc alerts shares of eagle pharmaceuticals inc nasdaqegrx opened at  on wednesday eagle pharmaceuticals inc has a month low of  and a month high of  the company has a market capitalization of  billion a pe ratio of  and a beta of  the firm’s day moving average is  and its day moving average is  eagle pharmaceuticals nasdaqegrx last announced its quarterly earnings data on monday may th the specialty pharmaceutical company reported  eps for the quarter missing analysts’ consensus estimates of  by  eagle pharmaceuticals had a net margin of  and a return on equity of  the firm had revenue of  million during the quarter compared to the consensus estimate of  million during the same period last year the business earned  eps the business’s revenue was up  on a yearoveryear basis on average equities research analysts anticipate that eagle pharmaceuticals inc will post  eps for the current fiscal year warning this report was first published by stock observer and is owned by of stock observer if you are reading this report on another site it was illegally stolen and reposted in violation of united states  international copyright  trademark laws the legal version of this report can be viewed at httpswwwthestockobservercomeaglepharmaceuticalsincegrxisproquestassociatesivllcslargestpositionupdatedupdatedupdatedhtml egrx has been the subject of a number of recent research reports bidaskclub cut shares of eagle pharmaceuticals from a “buy” rating to a “hold” rating in a report on friday june th piper jaffray companies set a  price objective on shares of eagle pharmaceuticals and gave the stock an “overweight” rating in a report on tuesday may th valuengine upgraded shares of eagle pharmaceuticals from a “buy” rating to a “strongbuy” rating in a report on tuesday may th royal bank of canada upped their price objective on shares of eagle pharmaceuticals from  to  and gave the stock an “outperform” rating in a report on tuesday may th finally zacks investment research cut shares of eagle pharmaceuticals from a “hold” rating to a “sell” rating in a report on wednesday may th two analysts have rated the stock with a sell rating two have assigned a hold rating three have assigned a buy rating and one has issued a strong buy rating to the company’s stock eagle pharmaceuticals has a consensus rating of “hold” and a consensus price target of  in other news major shareholder proquest investments iv lp sold  shares of eagle pharmaceuticals stock in a transaction dated tuesday april th the shares were sold at an average price of  for a total value of  the sale was disclosed in a filing with the securities  exchange commission which is available at the sec website also cfo pete a meyers acquired  shares of the firm’s stock in a transaction dated monday june th the stock was purchased at an average cost of  per share with a total value of  following the transaction the chief financial officer now owns  shares in the company valued at  the disclosure for this purchase can be found here in the last three months insiders bought  shares of company stock valued at  insiders own  of the company’s stock eagle pharmaceuticals company profile eagle pharmaceuticals inc is a specialty pharmaceutical company the company focuses on developing and commercializing injectable products in the critical care and oncology areas the company’s product portfolio includes products including argatroban ryanodex docetaxel injection nonalcohol formulation and bendeka receive news  ratings for eagle pharmaceuticals inc daily  enter your email address below to receive a concise daily summary of the latest news and analysts ratings for eagle pharmaceuticals inc and related companies with marketbeatcoms free daily email newsletter latest news sophos group plc receives gbx  consensus target price from analysts halliburton company forecasted to earn fy earnings of  per share headtohead comparison hsn  five below barclays plc raises incyte corporation price target to  barratt developments plc stock rating reaffirmed by peel hunt first midwest bank trust division cuts stake in simon property group inc leave a reply click here to cancel reply name required mail will not be published required website proquest associates iv llc cik  f filings searchf fund and stock screener stock reports fund reports support faq fulltext search custom software development policies  disclaimer contact us login or create an account proquest associates iv llc assets under management cik  q m change   change from trades   change from market  turnover  q m the data for two last quarters and top  holdings is shown free of charge create a paid account today starting at only  to get full access securities held by this fund quarterly values are s cusip security name historic max change from last q q q q q q q q q q q q q q  eagle pharmaceuticals inc                l immune design corp                l agile therapeutics inc                u anthera pharmaceuticals inc                q achillion pharmaceuticals in                h zosano pharma corp                 mast therapeutics inc                × find out what top hedge fund managers are really investing in picking stocks can be a very difficult process involving lots of research and a lot of uncertainty but what if you were able to quickly and easily tell what top hedge fund managers are investing in what if you could see where famous investors like warren buffet and david einhorn are putting their money well now you can – without spending hours going through f filings our searchf account doesn’t just allow you to track hedge fund investments it also keeps you on top of institutional investor trends lets you identify lowturnover portfolios allows you to determine the real causes of aum changes and much more this powerful tool will save your a lot of time and hard work and will give yourself the best chance to grow your earnings in the future get the full featurepacked version for just  close and never show again proquest associates iv llc company profile  bloomberg feedback proquest associates iv llc private company company profile sector financials industry asset management subindustry investment management proquest associates iv llc operates as an investment management firm corporate information address  vanderbilt beach road suite  naples fl  united states phone  fax  from the web sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft eagle pharmaceuticals nasdaqegrx stock price news  analysis eagle pharmaceuticals company profile nasdaqegrx company profile analyst ratings earnings history earnings estimates dividend history insider trade headlines social media chart about eagle pharmaceuticals nasdaqegrx eagle pharmaceuticals inc is a specialty pharmaceutical company the company focuses on developing and commercializing injectable products in the critical care and oncology areas the companys product portfolio includes products including argatroban ryanodex docetaxel injection nonalcohol formulation and bendeka its advanced candidates include ep bendamustine resistance temperature detectors rtd ep ep dantrolene sodium for exertional heat stroke ehs ep eglc dantrolene sodium for drug induced hyperthermia ep pemetrexed ep and eglc fulvestrant its product portfolio focuses on oncology critical care and orphan diseases bendamustine is an alkylating agent approved for use in chronic lymphocytic leukemia cll and indolent bcell nonhodgkins lymphoma nhl that has progressed during or within six months of treatment with rituximab or a rituximabcontaining regimen industry sector and symbol sector medical industry specialty  advanced pharmaceuticals subindustry na symbol nasdaqegrx cusip na web wwweagleuscom capitalizationmarket cap  millionoutstanding shares average prices day moving avg  day moving avg  week range    petrailing pe ratio foreward pe ratio pe growth sales  book valueannual revenue  millionprice  sales book value  per shareprice  book  profitabilityebidta  millionnet margins return on equity return on assets debtcurrent ratio quick ratio miscaverage volume  shsbeta short ratio    frequently asked questions for eagle pharmaceuticals nasdaqegrx what is eagle pharmaceuticals stock symbol eagle pharmaceuticals trades on the nasdaq under the ticker symbol egrx how were eagle pharmaceuticals earnings last quarter eagle pharmaceuticals inc nasdaqegrx released its earnings results on monday may th the company reported  earnings per share for the quarter missing the consensus estimate of  by  the firm earned  million during the quarter compared to analysts expectations of  million eagle pharmaceuticals had a return on equity of  and a net margin of  the businesss revenue was up  on a yearoveryear basis during the same period last year the business earned  earnings per share view eagle pharmaceuticals earnings history where is eagle pharmaceuticals stock going where will eagle pharmaceuticals stock price be in   brokerages have issued  month target prices for eagle pharmaceuticals stock their forecasts range from  to  on average they anticipate eagle pharmaceuticals share price to reach  in the next year view analyst ratings for eagle pharmaceuticals what are analysts saying about eagle pharmaceuticals stock here are some recent quotes from research analysts about eagle pharmaceuticals stock  according to zacks investment research eagle pharmaceuticals inc is a specialty pharmaceutical company it focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the united states the company markets ep to treat heparininduced thrombocytopenia it develops ep ep ryanodex and ep eagle pharmaceuticals inc is based in woodcliff lake new jersey    mizuho analysts commented we remain cautious on  revenue the exertional heat stroke ehs launch and lower takeout probability eagle reported q revs of m and gaap eps of  vs factset consensus m and  mgmt introduced fy sga guidance of m and m in rd consensus models are in line with these expense ranges but we think that  revenue expectations particularly ryanodex need to come down based on a slower ehs ramp because we now have a better appreciation for the hurdles associated with this launch we also lowered our probability of takeout to  from  previously on a standalone basis we think that egrx is only worth share so the stock already reflects expectations of a takeout in our view we reiterate our underperform rating and  pt which are based on a weighted blend of dcf  and sotp  valuations  who are some of eagle pharmaceuticals key competitors some companies that are related to eagle pharmaceuticals include repligen corporation rgen therapeuticsmd txmd therapeuticsmd txmd aimmune therapeutics aimt rockwell medical rmti assembly biosciences asmb novan inc novn checkcap chek cormedix crmd dara biosciences dara macrocure ltd mcur and salix pharmaceuticals slxp who are eagle pharmaceuticals key executives eagle pharmaceuticals management team includes the folowing people michael graves independent chairman of the boardscott l tarriff chief executive officer independent directorpete a meyers chief financial officer principal financial officer principal accounting officerdavid e riggs chief financial officersteven l krill phd executive vice president chief scientific officeradrian j hepner md phd executive vice president chief medical officerdouglas l braunstein independent directorrichard a edlin independent directorsander a flaum independent directorrobert l glenning independent director who owns eagle pharmaceuticals stock eagle pharmaceuticals stock is owned by a variety of of retail and institutional investors top institutional shareholders include russell investments group ltd  hershey trust co  james investment research inc  great west life assurance co can  fisher asset management llc  and strs ohio  company insiders that own eagle pharmaceuticals stock include david pernock michael graves pete a meyers proquest investments iv lp proquest management llc richard a edlin sander a flaum sander a flaum scott tarriff steven b ratoff and steven l krill view institutional ownership trends for eagle pharmaceuticals who sold eagle pharmaceuticals stock who is selling eagle pharmaceuticals stock eagle pharmaceuticals stock was sold by a variety of institutional investors in the last quarter including capstone asset management co and louisiana state employees retirement system company insiders that have sold eagle pharmaceuticals stock in the last year include proquest investments iv lp sander a flaum steven b ratoff and steven l krill view insider buying and selling for eagle pharmaceuticals who bought eagle pharmaceuticals stock who is buying eagle pharmaceuticals stock eagle pharmaceuticals stock was acquired by a variety of institutional investors in the last quarter including russell investments group ltd hershey trust co james investment research inc hamilton lane advisors llc aperio group llc fisher asset management llc bank of montreal can and strs ohio company insiders that have bought eagle pharmaceuticals stock in the last two years include david pernock michael graves pete a meyers and richard a edlin view insider buying and selling for eagle pharmaceuticals how do i buy eagle pharmaceuticals stock shares of eagle pharmaceuticals can be purchased through any online brokerage account popular online brokerages include vanguard brokerage services td ameritrade etrade scottrade fidelity and charles schwab what is eagle pharmaceuticals stock price today one share of eagle pharmaceuticals stock can currently be purchased for approximately  marketbeat community rating for eagle pharmaceuticals nasdaq egrxcommunity ranking   out of     outperform votes   vote outperformunderperform votes   vote underperformtotal votes  marketbeats community ratings are surveys of what our community members think about eagle pharmaceuticals and other stocks vote outperform if you believe the stock will outperform the sp  over the long term vote underperform if you believe the stock will underperform the sp  over the long term you may vote once every thirty days analyst ratings consensus ratings for eagle pharmaceuticals nasdaqegrx how are consensus ratings calculated marketbeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months since brokers often use different ratings systems each rating is normalized to a standardized rating score of  sell  hold  buy or  strong buy consensus ratings scores are calculated using the mean average of the number of normalized sell hold buy and strong buy ratings each stocks consensus rating is derived from its calculated consensus ratings score   sell   hold   buy   strong buy marketbeats consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve monthsmarketbeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and marketbeat has received a report that coverage was dropped ratings from certain research firms that issue ratings using purely quantitative methods such as zacks vetr and valuengine are not included in consensus calculations marketbeats consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available dataratings breakdown  sell rating  buy ratingsconsensus ratingbuy score consensus price target   upside analysts ratings history for eagle pharmaceuticals nasdaqegrx show only the most recent rating from each brokerage all ratings for this stock datefirmactionratingprice targetimpact on share pricedetailsroyal bank of canadalower price targetoutperform  outperform  mediummizuholower price targetunderperform  underperform  mediumpiper jaffray companiesset price targetbuymediumwilliam blairboost price targetoutperform  nadata available from  forward earnings earnings history for eagle pharmaceuticals nasdaqegrxearnings history by quarter for eagle pharmaceuticals nasdaq egrxdatequarterconsensus estimateactual epsrevenue estimateactual revenuerelease linkconference calldetailsq  million millionviewlistenq million millionviewlistenq million millionviewlistenq million millionviewnaq million millionviewnaq million millionviewlistenq million millionviewlistenq million millionviewlistenq million millionviewlistenq million millionviewnaq million millionviewnaq million millionviewnadata available from  forward estimates earnings estimates for eagle pharmaceuticals nasdaqegrx eps consensus estimate quarternumber of estimateslow estimatehigh estimateaverage estimateq q q q data provided by zacks investment research dividends dividend history for eagle pharmaceuticals nasdaqegrxno dividend announcements for this company have been tracked by marketbeatcom insider trades insider trading and institutional ownership history for eagle pharmaceuticals nasdaqegrxinsider ownership percentage insider trades by quarter for eagle pharmaceuticals nasdaqegrxtransaction dateinsider nametitlebuysellnumber of sharesaverage share pricetotal transactiondetailspete a meyerscfobuy  david pernockinsiderbuy  david pernockinsiderbuy  proquest investments iv lpmajor shareholdersell  proquest investments iv lpmajor shareholdersell  proquest investments iv lpmajor shareholdersell  proquest investments iv lpmajor shareholdersell  proquest investments iv lpmajor shareholdersell  proquest investments iv lpmajor shareholdersell  steven l krillevpsell  richard a edlindirectorbuy  david pernockinsiderbuy  proquest investments iv lpmajor shareholdersell  david pernockinsiderbuy  proquest investments iv lpmajor shareholdersell  steven b ratoffdirectorsell  sander a flaumdirectorsell  proquest investments iv lpmajor shareholdersell  proquest investments iv lpmajor shareholdersell  proquest investments iv lpmajor shareholdersell  proquest investments iv lpmajor shareholdersell  proquest investments iv lpmajor shareholdersell  proquest investments iv lpmajor shareholdersell  proquest investments iv lpmajor shareholdersell  proquest investments iv lpmajor shareholdersell  proquest investments iv lpmajor shareholdersell  proquest investments iv lpmajor shareholdersell  proquest investments iv lpmajor shareholdersell  proquest investments iv lpmajor shareholdersell  proquest management llcmajor shareholdersell  scott tarriffceosell  michael gravesdirectorbuy  scott tarriffceosell  sander a flaumdirectorsell  scott tarriffceosell  scott tarriffceosell  scott tarriffceosell  scott tarriffceosell  scott tarriffceosell  steven l krillinsidersell  jay moorindirectorbuy  data available from  forward headlines headline trends for eagle pharmaceuticals nasdaqegrx latest headlines for eagle pharmaceuticals nasdaqegrx source all sources trusted sources marketbeatcom bloomberg marketwatch motley fool nasdaq reuters seeking alpha the street the wall street journal yahoo finance dateheadlinerefilefda rejects eagle pharmaceuticals heat stroke treatmentwwwnasdaqcom  july  at  ameagle pharmaceuticals inc egrx plunged after fda complete response letterwwwrttnewscom  july  at  ameagle pharmaceuticals inc egrx pt set at  by piper jaffray companieswwwamericanbankingnewscom  july  at  pmfda rejects eagle pharmaceuticals heat stroke treatment  nasdaqwwwnasdaqcom  july  at  pmeagle pharmaceuticals egrx receives crl from fda on ryanodex for exertional heat stroke application  streetinsidercomwwwstreetinsidercom  july  at  pmupdate eagle pharma stock plummets  on news that heat stroke drug failed to get fda approval  marketwatchwwwmarketwatchcom  july  at  pmeagle pharmaceuticals receives complete response letter from fda on ryanodex for exertional heat stroke applicationfinanceyahoocom  july  at  pmupdate eagle pharma stock plummets  on news that heat stroke drug failed to get fda approvalfinanceyahoocom  july  at  pmfda rejects eagle pharmaceuticals heat stroke treatmentfinanceyahoocom  july  at  pmmizuho top analyst buzzes mayday as eagle pharmaceuticals inc egrx valuation likely to collapsefinanceyahoocom  july  at  pmeagle pharmaceuticals egrx publishes statement regarding ryanodex application pdufa date for exertional heat strokewwwstreetinsidercom  july  at  ameagle pharmaceuticals egrx publishes statement regarding   streetinsidercomwwwstreetinsidercom  july  at  pmeagle pharmaceuticals inc issues statement regarding ryanodex application pdufa date for exertional heat strokefinanceyahoocom  july  at  pmeagle pharmaceuticals inc nasdaqegrx receives average recommendation of hold from analystswwwamericanbankingnewscom  july  at  ametfs with exposure to eagle pharmaceuticals inc  july  financeyahoocom  july  at  pmeagle pharmaceuticals inc egrx given a  price target at royal bank of canadawwwamericanbankingnewscom  july  at  ametfs with exposure to eagle pharmaceuticals inc  july  financeyahoocom  july  at  pmeagle pharmaceuticals inc breached its  day moving average in a bearish manner  egrxus  july  financeyahoocom  july  at  pmeagle pharmaceuticals inc egrx upgraded to hold by zacks investment researchwwwamericanbankingnewscom  july  at  pmeagle pharmaceuticals upcoming catalysts provide support for mediumterm playseekingalphacom  july  at  amcontrasting eagle pharmaceuticals nasdaqegrx  mallinckrodt plc mnkwwwamericanbankingnewscom  july  at  amtop stocks to look for on july’s fda calendarwallstcom  july  at  pmeagle pharmaceuticals inc nasdaqegrx lowered to hold at bidaskclubwwwamericanbankingnewscom  june  at  pmeagle pharmaceuticals inc egrx given average rating of buy by brokerageswwwamericanbankingnewscom  june  at  pmeagle pharmaceuticals inc breached its  day moving average in a bullish manner  egrxus  june  financeyahoocom  june  at  amthese  stocks are up over  in the last  yearsfinanceyahoocom  june  at  pmeagle pharmaceuticals inc egrx upgraded to buy at bidaskclubwwwamericanbankingnewscom  june  at  pmetfs with exposure to eagle pharmaceuticals inc  june  financeyahoocom  june  at  pmeagle pharmaceuticals egrx shares cross above  dmawwwnasdaqcom  june  at  pmeagle pharmaceuticals inc egrxus earnings analysis q  by the numbers  june  financeyahoocom  june  at  pminsider buying eagle pharmaceuticals inc egrx cfo acquires  shares of stockwwwamericanbankingnewscom  june  at  pmwhat falling estimates  price mean for eagle pharmaceuticals egrx  nasdaqwwwnasdaqcom  june  at  pmwhat falling estimates  price mean for eagle pharmaceuticals egrxfinanceyahoocom  june  at  pmeagle pharmaceuticals inc egrx given average rating of hold by analystswwwamericanbankingnewscom  june  at  ameagle pharmaceuticals inc to present at investor conferences in june  business wire press releasewwwbusinesswirecom  june  at  ameagle pharmaceuticals inc to present at investor conferences in junefinanceyahoocom  may  at  pmeagle pharmaceuticals egrx shares cross below  dma  nasdaqwwwnasdaqcom  may  at  pmeagle pharmaceuticals egrx underperform rating reaffirmed at mizuhowwwamericanbankingnewscom  may  at  pmeagle pharmaceuticals inc egrx insider buys  in stockwwwamericanbankingnewscom  may  at  pmeagle pharmaceuticals inc egrx insider purchases  in stockwwwamericanbankingnewscom  may  at  pmvaluengine upgrades eagle pharmaceuticals inc egrx to strongbuywwwamericanbankingnewscom  may  at  pmeagle pharmaceuticals inc egrx dropped after new cfo appointedwwwrttnewscom  may  at  pmeagle pharmaceuticals inc breached its  day moving average in a bearish manner  egrxus  may  financeyahoocom  may  at  pmeagle pharmaceuticals inc egrx short interest updatewwwamericanbankingnewscom  may  at  ameagle pharmaceuticals inc egrx is losing ground after new cfo namedwwwnasdaqcom  may  at  ameagle pharmaceuticals appoints pete a meyers as chief financial officerfinanceyahoocom  may  at  amedited transcript of egrx earnings conference call or presentation may pm gmtfinanceyahoocom  may  at  pmq  eps estimates for eagle pharmaceuticals inc egrx decreased by analystwwwamericanbankingnewscom  may  at  ameagle pharmaceuticals inc egrx downgraded by zacks investment researchwwwamericanbankingnewscom  may  at  pmeagle pharmaceuticals inc to present at bank of america merrill lynch  health care conferencefinanceyahoocom  may  at  pm social chart eagle pharmaceuticals egrx chart for friday july   this page was last updated on  by marketbeatcom staff proquest associates iv llc top holdings f filings home articles latest filings all funds stocks being bought stocks being sold insider buying free registration required to continue you have viewed  pages within the last  hours to continue please register at holdings channel for unlimited page views and our free weekly newsletter by entering your name and email address below registration is absolutely free by registering you agree to our privacy policy  terms of use if you are in canada you must click here for alternate registration page problems with your registration sticking enable your browser to receive our cookie to resolve other questions email us at infoholdingschannelcom proquest associates iv llc top holdings f filings  wwwholdingschannelcom  copyright     all rights reserved nothing in holdings channel is intended to be investment advice nor does it represent the opinion of counsel from or recommendations by bnk invest inc or any of its affiliates subsidiaries or partners none of the information contained herein constitutes a recommendation that any particular security portfolio transaction or investment strategy is suitable for any specific person all viewers agree that under no circumstances will bnk invest inc its subsidiaries partners officers employees affiliates or agents be held liable for any loss or damage caused by your reliance on information obtained by visiting using or viewing this site you agree to the following full disclaimer  terms of use and privacy policy video widget and market videos powered by market news video quote and option data delayed at least  minutes stock quote data powered by ticker technologies and mergent contact holdings channel meet our editorial staff f portfolio proquest associates iv llc stock ideas hedge fund trade spotlight high conviction ipo stocks biotech stocks that hedge funds are buying top undervalued stock picks  stocks that matter most to hedge funds stocks validate your stock consensus stock picks realtime insights hedge funds hedge fund portfolios hedge fund managers find your hedge fund match hm pro pro stock screener institutional portfolios institutional investors sign insubscribe nowweeks free trial hedgemindcom   institutional portfolios   proquest associates iv llc    find institutional investor institutional investor browse institutional investors time period activityallnewincreasedunchangeddecreasedsold out security typeallstockoptions put callfixed income top percentileuse this filter to see holdings within a selected percentile portfoliofor example click  to show only holdings in the top  percentile sectorsuse the pull down list to add one or more sectors to the space below and click apply to filter out the holdings that belong to your selected sectorsapply clear select a sector basic industriescapital goodsconsumer durablesconsumer nondurablesconsumer servicesenergyfinancehealth caremiscellaneouspublic utilitiestechnologytransportationnaunidentified stock stylestock style shows hedge fund managers main investment focus in value or growth it is determined based on analysis of portfolio holdings that are part of about  us stocksresetstylemarket caplargevaluemidblendsmallgrowth proquest associates iv llc time period total holdings total value x activities newincreasedunchangeddecreasedsold out top stock holdingstotal  egrxagrximdz  hover over a symbol below for details  sec ffilingdetail sortportfolio weight growth or valueposition valuechange ratesectorazgraphegrxcomagrxcomimdzcom   hedgemindcom llc all rights reserved site mapdisclaimertermsprivacycontact us proquest associates iv llc top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active proquest associates iv llc • naples fl how do i update this listing proquest associates iv is based out of naples their last reported f filing for q  included  in managed f securities and a top  holdings concentration of  proquest associates ivs largest holding is eagle pharmaceuticals inc with shares held of  whalewisdom has at least  f filings in our database for proquest associates iv summary f holdings ind managers dg insider form  download f summary to excel download f summary to excel create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from proquest associates iv llc enter your email address below and choose submit your email cancel  top buys name change  top sells name change  f holdings summary stock port egrx eagle pharmaceuticals inc  agrx agile thrpeutics  imdz immune design  see all holdings  f activity market value  million prior market value  million new purchases stocks additional purchases stocks sold out of stocks reduced holdings in stock top  holdings  turnover   turnover alt   time held top quarters time held top quarters time held all quarters  turnover is calculated by taking the  of new holdings initial purchases  the  of positions sold out of not just reduced divided by the total  of holdings for the quarter  alt turnover is calculated by taking either the total mv of new purchases or the mv of securities sold whichever is less divided by the total mv of the fund  f sector allocation over time fund metrics you are limited to the prior  quarters of f filings subscribe to whalewisdom to view all filing data for proquest associates iv llc portfolio performance top  equalweighted holdings last updated on  performance for q   performance last  quarters  performance metrics stats are not available for the latest quarter backtester use whalewisdoms backtester tool to test how a hypothetical portfolio would have performed with different investment strategies research one or more filers performance and then optimize their portfolios to match your own investment goals start with one of our predefined groups or create your own view the backtesting whitepaper and the getting started page for additional help take a tour save changes to tracked backtest saving generate report at least one fund must be selected before running a backtest  ending sector allocation quarter to view current combined fdg q  f filings q  f filings q  f filings q  f filings q  f filings q  f filings q  f filings q  f filings q  f filings subscription required q  f filings subscription required refresh advanced export download csv download excel xlsx download tsv click to see additional filters security types shares calls puts principal changes in holdings new position added to position reduced position closed out position no change ranking is in the top minimum  of shares stock ticker is etf yesno refresh edit columns shares are split adjusted × report an error your name optional your email optional error to report or any other commentsrequired cancel click here to report any possible errors with this listing f filings available   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required   fhra subscription required   fhr subscription required   fhr subscription required   fhr subscription required × csv export module this will schedule a job to export all requested f holdings data for this filer when completed an email will be sent to the email address you specify containing a link to download the zip file of the csv files you requested output type output all f holdings into a single csv file output all f holdings into separate csv files per quarter columns to include filer name stock name stock ticker quarter date type of security current shares held current market value previous shares held previous market value current  of portfolio previous  of portfolio current rank previous rank change in shares type of change sector f quarters to include         email address to send data to cancel schedule export this lets you look at individual sub managers or subsidiaries within the f filing quarter         manager optionally compare to quarter          manager  number of shares is not splitadjusted schedule d and g events since  subscription required form   nonderivative insider transactions since  loading elevate your investments try it for free